BioPoly Partial Resurfacing Knee Implant
Focal cartilage defects in the knee
Phase 3Investigational Device in U.S.; Clinical Study Enrolling
Key Facts
Indication
Focal cartilage defects in the knee
Phase
Phase 3
Status
Investigational Device in U.S.; Clinical Study Enrolling
Company
About BioPoly
BioPoly, a spin-off from Schwartz Biomedical, is pioneering a novel class of orthopedic implants with its patented BioPoly material, which mimics natural cartilage function. The company has commercial products for the toe and radial head, an FDA-approved knee implant in clinical study, and is focused on expanding its pipeline for joint preservation. Founded and led by a team of seasoned experts in Fort Wayne, Indiana, BioPoly aims to bridge the gap between biological treatments and total joint arthroplasty.
View full company profile